Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1990 May 26;300(6736):1352–1353. doi: 10.1136/bmj.300.6736.1352

Graves' ophthalmopathy.

B W Fleck 1, A D Toft 1
PMCID: PMC1663001  PMID: 2196944

Full text

PDF
1352

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartalena L., Marcocci C., Bogazzi F., Panicucci M., Lepri A., Pinchera A. Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism. N Engl J Med. 1989 Nov 16;321(20):1349–1352. doi: 10.1056/NEJM198911163212001. [DOI] [PubMed] [Google Scholar]
  2. Enzmann D. R., Donaldson S. S., Kriss J. P. Appearance of Graves' disease on orbital computed tomography. J Comput Assist Tomogr. 1979 Dec;3(6):815–819. [PubMed] [Google Scholar]
  3. Glinoer D., Etienne-Decerf J., Schrooyen M., Sand G., Hoyoux P., Mahieu P., Winand R. Beneficial effects of intensive plasma exchange followed by immunosuppressive therapy in severe Graves' ophthalmopathy. Acta Endocrinol (Copenh) 1986 Jan;111(1):30–38. doi: 10.1530/acta.0.1110030. [DOI] [PubMed] [Google Scholar]
  4. Harnett A. N., Doughty D., Hirst A., Plowman P. N. Radiotherapy in benign orbital disease. II: Ophthalmic Graves' disease and orbital histiocytosis X. Br J Ophthalmol. 1988 Apr;72(4):289–292. doi: 10.1136/bjo.72.4.289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hedin A. Eyelid surgery in dysthyroid ophthalmopathy. Eye (Lond) 1988;2(Pt 2):201–206. doi: 10.1038/eye.1988.37. [DOI] [PubMed] [Google Scholar]
  6. Hägg E., Asplund K. Is endocrine ophthalmopathy related to smoking? Br Med J (Clin Res Ed) 1987 Sep 12;295(6599):634–635. doi: 10.1136/bmj.295.6599.634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kendall-Taylor P., Crombie A. L., Stephenson A. M., Hardwick M., Hall K. Intravenous methylprednisolone in the treatment of Graves' ophthalmopathy. BMJ. 1988 Dec 17;297(6663):1574–1578. doi: 10.1136/bmj.297.6663.1574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kendall-Taylor P. The management of Graves' ophthalmopathy. Clin Endocrinol (Oxf) 1989 Dec;31(6):747–756. doi: 10.1111/j.1365-2265.1989.tb01296.x. [DOI] [PubMed] [Google Scholar]
  9. Kriss J. P., Konishi J., Herman M. Studies on the pathogenesis of Graves' ophthalmopathy (with some related observations regarding therapy). Recent Prog Horm Res. 1975;31:533–566. doi: 10.1016/b978-0-12-571131-9.50018-9. [DOI] [PubMed] [Google Scholar]
  10. Sisson J. C., Vanderburg J. A. Lymphocyte-retrobulbar fibroblast interaction: mechanisms by which stimulation occurs and inhibition of stimulation. Invest Ophthalmol. 1972 Jan;11(1):15–20. [PubMed] [Google Scholar]
  11. Sridama V., DeGroot L. J. Treatment of Graves' disease and the course of ophthalmopathy. Am J Med. 1989 Jul;87(1):70–73. doi: 10.1016/s0002-9343(89)80485-1. [DOI] [PubMed] [Google Scholar]
  12. Trokel S. L., Jakobiec F. A. Correlation of CT scanning and pathologic features of ophthalmic Graves' disease. Ophthalmology. 1981 Jun;88(6):553–564. doi: 10.1016/s0161-6420(81)34993-8. [DOI] [PubMed] [Google Scholar]
  13. Warren J. D., Spector J. G., Burde R. Long-term follow-up and recent observations on 305 cases of orbital decompression for dysthyroid orbitopathy. Laryngoscope. 1989 Jan;99(1):35–40. doi: 10.1288/00005537-198901000-00008. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES